GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G1 Therapeutics Inc (STU:G1H) » Definitions » PB Ratio

G1 Therapeutics (STU:G1H) PB Ratio : 14.72 (As of Dec. 14, 2024)


View and export this data going back to 2018. Start your Free Trial

What is G1 Therapeutics PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-12-14), G1 Therapeutics's share price is €6.39. G1 Therapeutics's Book Value per Share for the quarter that ended in Jun. 2024 was €0.43. Hence, G1 Therapeutics's PB Ratio of today is 14.72.

Warning Sign:

G1 Therapeutics Inc stock PB Ratio (=15.31) is close to 5-year high of 16.630000

The historical rank and industry rank for G1 Therapeutics's PB Ratio or its related term are showing as below:

STU:G1H' s PB Ratio Range Over the Past 10 Years
Min: 1.11   Med: 3.51   Max: 15.31
Current: 15.31

During the past 9 years, G1 Therapeutics's highest PB Ratio was 15.31. The lowest was 1.11. And the median was 3.51.

STU:G1H's PB Ratio is not ranked
in the Biotechnology industry.
Industry Median: 2.48 vs STU:G1H: 15.31

During the past 12 months, G1 Therapeutics's average Book Value Per Share Growth Rate was -58.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -47.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -41.00% per year.

During the past 9 years, the highest 3-Year average Book Value Per Share Growth Rate of G1 Therapeutics was 12.30% per year. The lowest was -47.30% per year. And the median was -35.70% per year.

Back to Basics: PB Ratio


G1 Therapeutics PB Ratio Historical Data

The historical data trend for G1 Therapeutics's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G1 Therapeutics PB Ratio Chart

G1 Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only 3.95 3.84 3.02 4.00 4.29

G1 Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.20 1.59 4.29 8.34 4.75

Competitive Comparison of G1 Therapeutics's PB Ratio

For the Biotechnology subindustry, G1 Therapeutics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G1 Therapeutics's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G1 Therapeutics's PB Ratio distribution charts can be found below:

* The bar in red indicates where G1 Therapeutics's PB Ratio falls into.



G1 Therapeutics PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

G1 Therapeutics's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=6.39/0.434
=14.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


G1 Therapeutics  (STU:G1H) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


G1 Therapeutics PB Ratio Related Terms

Thank you for viewing the detailed overview of G1 Therapeutics's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


G1 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
700 Park Offices Drive, Suite 200, Research Triangle Park, NC, USA, 27709
G1 Therapeutics Inc is a commercial-stage biopharmaceutical company. It is engaged in developing novel, small-molecule therapies to target unmet needs in the treatment of cancer. The firm is developing drugs that have the potential to treat the types of cancer, such as cell lung cancer and breast cancer, and designs them to combine and enhance the anti-tumor activity of current therapies. Its product COSELA indicates to help protect bone marrow from the damage of chemotherapy.

G1 Therapeutics Headlines

No Headlines